Newsletter of MEDICA | View in browser | Deutsch | Print
Header of MEDICA Newsletter

Vascular chips: more precise drug tests without animal testing

Dear Sir or Madam,

Vascular chips that replicate human tissue could increase the reliability of drug tests, reduce the reliance on animal testing and enable more realistic predictions in the preclinical phase. Human cells can be used to study the effects of drugs in more detail, which could make clinical trials more efficient and ethical.

Enjoy reading!

Tim Plato
Editorial team MEDICA-tradefair.com

Table of Contents

Interview: How vessel-chips are changing drug testing
Submit your solution to the Healthcare Innovation World Cup
13th MEDICA Start-up COMPETITION - Submit your solutions
Newsletter Service

From lab to market: How vessel-chips are changing drug testing

Interview – LAB & DIAGNOSTICS

Image: Examination of cell cultures in a laboratory
How can vascular chips change the future of drug testing? In our interview with Dr. Abhishek Jain, you can find out how this technology reduces animal testing and improves the accuracy of pharmaceutical development.
Click here for the interview
This is how vascular chip technology optimizes drug testing and reduces animal testing.
Image: Banner with the text: Discover the world of LAB & DIAGNOSTICS here; Copyright: Messe Düsseldorf
To top

Countdown is on - Only 3 Weeks Left to Submit Your Solution to the 16th Healthcare Innovation World Cup

Image: Graphic for the "16TH Healtcare Innovation World Cup"; Copyright: Messe Düsseldorf

There are only 3 weeks to take part in the 16th Healthcare Innovation World Cup® with smart health devices, medical wearables, digital biomarkers, electroceuticals, intelligent patches and more.

Participants can win speaking slots in the grand pitch finals at MEDICA, business connections with corporates and investors, free dev kits, and global visibility. The pitch and award ceremony will be on November 11 at the 11th MEDICA INNOVATION FORUM (Hall 13, E63).

Interested in partner packages: please contact s.sulzmaier@navispace.de

The competition also offers the opportunity to participate in two special prizes:

VIVE XR Healthcare Challenge
Smart Clothing Challenge
Submit your solution by September 14, 2024 (free)
To top

Identifying a high-risk biomarker for gastric cancer recurrence risk

News

LAB & DIAGNOSTICS

A recent study led by researchers at the Medical University of Vienna has identified the AF1Q gene as a significant biomarker for predicting the risk of gastric cancer relapse. This discovery could enhance personalized treatment strategies and improve survival rates for patients. The study was published in Scientific Reports.
read more
To top

3D-printed blood vessels offer new hope for heart bypass surgery

News

LAB & DIAGNOSTICS

Researchers at the University of Edinburgh have developed 3D-printed blood vessels that mimic the properties of human veins. These artificial vessels could significantly improve the outcomes of heart bypass surgeries by reducing complications such as scarring, pain, and infection.
read more
To top

Final 3 Weeks to Apply for the 13th MEDICA Start-up COMPETITION 2024

Image: Graphic for the "13TH MEDICA Start-Up Competition"; Copyright: Messe Düs

Only 3 weeks left to join the 13th MEDICA Start-up COMPETITION! Showcase your health apps, AI in healthcare, robotics, and lab diagnostic solutions to industry leaders and investors. The pitch and award ceremony will be held at the 11th MEDICA INNOVATION FORUM on November 12 (Hall 13, E63).

Gain international exposure at MEDICA 2024, present to investors, receive free marketing, and cash prizes up to €3,500.

If you are interested in becoming a partner of the MEDICA Start-up COMPETITION please contact s.sulzmaier@navispace.de.

Deadline: September 14, 2024. Apply now for free at
To top

Company News, MED TECH & DEVICES

Neuroelectrics Announces Results of Telemedicine Pilot Depression Study with Starstim tDCS Therapy

Neuroelectrics Barcelona SLU

read more
64% median percentage reduction in observer-rated MADRS scores, indicating significant and clinically meaningful improvement in depressive symptoms, with over 70% of participants demonstrating a ≥50%...
To top

LAB & DIAGNOSTICS, Company News

New Opportunity for Cancer Therapy: Miniature Lab Provides Insights into Metastases Development

Fraunhofer-Institut für Werkstoff- und Strahltechnik IWS Dresden

read more
Every year, around half a million people in Germany are diagnosed with cancer. Despite the existence of effective treatment options for many types of cancer, many questions about the development of...
To top

LAB & DIAGNOSTICS, Company News

Radioactive Substances Fight Cancer in the Mini-lab

Fraunhofer-Institut für Werkstoff- und Strahltechnik IWS Dresden

read more
Radioactivity can save lives. When neither chemotherapy or surgery nor radiation from the outside help against a tumor, modern medicine uses so-called radiopharmaceuticals. These radioactive drugs...
To top

Newsletter Service

You like our newsletter? Then please recommend us: Forward this newsletter or the link www.MEDICA.de/news_login_2 to your friends and colleagues.

If you have difficulties with your order, please write an e-mail to redaktion@medica.de.

To top
Legal disclaimer

Messe Düsseldorf GmbH
Messeplatz, Stockumer Kirchstr. 61
40474 Düsseldorf, Germany

Phone: +49 211 4560-01
Fax: +49 211 4560-668
www.messe-duesseldorf.de
info@messe-duesseldorf.de

County Court Düsseldorf HRB 63

Board of Managing Directors: Wolfram N. Diener (Chairman), Marius Berlemann, Bernhard J. Stempfle

Chairman of Supervisory Board: Mayor Dr. Stephan Keller

Messe Düsseldorf GmbH processes personal data relating to you. You can find more information - also on your rights - in the privacy policy of Messe Düsseldorf GmbH available at www.messe-duesseldorf.de/privacy. In principle, i.e. subject to legal restrictions, you may at any time object to the processing of your personal data either on the aforementioned website, via e-mail to privacy@messe-duesseldorf.de or via postal mail to Messe Düsseldorf GmbH, G2-RV, PF 101006, 40001 Düsseldorf, Germany.

Facebook LinkedIn YouTube

Should you no longer wish to receive our newsletter, please click here.